Silence Therapeutics PLC
OTC:SLNCF
Cash Flow Statement
Cash Flow Statement
Silence Therapeutics PLC
| Dec-2019 | Jun-2020 | ||
|---|---|---|---|
| Operating Cash Flow | |||
| Net Income |
(23)
|
(27)
|
|
| Depreciation & Amortization |
0
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
|
| Cash Taxes Paid |
(2)
|
(2)
|
|
| Change in Working Capital |
23
|
38
|
|
| Cash from Operating Activities |
2
N/A
|
13
+642%
|
|
| Investing Cash Flow | |||
| Capital Expenditures |
(0)
|
(0)
|
|
| Other Items |
(15)
|
(35)
|
|
| Cash from Investing Activities |
(15)
N/A
|
(36)
-137%
|
|
| Financing Cash Flow | |||
| Net Issuance of Common Stock |
5
|
21
|
|
| Cash from Financing Activities |
5
N/A
|
21
+296%
|
|
| Change in Cash | |||
| Effect of Foreign Exchange Rates |
0
|
1
|
|
| Net Change in Cash |
(8)
N/A
|
(1)
+85%
|
|
| Free Cash Flow | |||
| Free Cash Flow |
2
N/A
|
12
+623%
|
|